trending Market Intelligence /marketintelligence/en/news-insights/trending/a9G9KzWAI_HqkunHOGoUOw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

GHO Capital acquires early phase drug developer from Mentha Capital

Street Talk - Ep. 64: Coronavirus jumpstarts digital adoption

Street Talk Podcast

Street Talk - Ep. 63: Deal talks continue amid bank M&A freeze, setting up for strong Q4

Street Talk Podcast

Street Talk - Ep. 62: 'Brutal' outlook for oil demand offers banks in oil patch no relief

Amid Q1 APAC Fintech Funding Slump, Payment Companies Drove Investments

GHO Capital acquires early phase drug developer from Mentha Capital

Specialist healthcare investment adviser GHO Capital Partners LLP acquired Ardena Holding NV and its existing management from Amsterdam-based Mentha Capital BV.

Alvarez & Marsal, Deloitte, Sidley Austin LLP, Loyens & Loeff NV, CIL Management Consultants, E&Y’s Life Sciences Corporate Finance Team, Matrix Global Services Ltd., AON, ERM and Saola Healthcare Partners advised GHO on the transaction.

William Blair, Deloitte, LEK Consulting, deBreij, Schoups, Delphi, Ellex, CorporateWise, van Doorne and ERM advised Ardena.

GHO recently announced the close of their second specialist healthcare private equity fund at its hard cap of €975 million and last year completed investments in Sterling Pharma and BioAgilytix, as well as exits from Quotient Sciences and Caprion Biosciences.

Belgium-headquartered Ardena is a multiservice contract development and manufacturing organization focused on early phase drug development.